Costimulatory molecules in human atherosclerotic plaques: An indication of antigen specific T lymphocyte activation

Atherosclerosis

Volumn 133, Issue 2, 1997, Pages 227-234

  De Boer, Onno J ^a   Hirsch, Floris ^a   Van Der Wal, Allard C ^a   Van Der Loos, Chris M ^a   Das, Pranab K ^a   Becker, Anton E ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Immune mechanisms in atherosclerosis; Immunocytochemical methods; Inflammation and atherosclerosis; T cell stimulation

Indexed keywords

ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD19; ANTIGENS, CD22; ANTIGENS, CD27; ANTIGENS, CD28; ANTIGENS, CD3; ANTIGENS, CD70; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ARTERIES; ARTERIOSCLEROSIS; CELL ADHESION MOLECULES; ENDOTHELIUM, VASCULAR; EPITOPES; HUMANS; IMMUNOHISTOCHEMISTRY; LECTINS; LYMPHOCYTE ACTIVATION; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MIDDLE AGED; T-LYMPHOCYTES;

EID: 0030848708     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00135-4     Document Type: Article

References (35)

1. Hanson G.K., Jonasson L., Seifert P.S., Stemme S. Immune mechanisms in atherosclerosis. Arteriosclerosis. 9:1989;567-578.
2. Hansson G.K. Immune and inflammatory mechanisms in the development of atherosclerosis. Br Heart J. 69:1993;S38-S41.
3. Van der Wal A.C., Das P.K., Bentz van de Berg D., van der Loos C.M., Becker A.E. Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest. 61:1989;166-170.
4. Stemme S., Holm J., Hansson G.K. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler Thromb. 12:1992;206-211.
5. Kishikawa H., Shimokama T., Watanabe T. Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima: role of cell-mediated immunity in human atherogenesis. Virchows Arch. 423:1993;433-442.
6. Van der Wal A.C., Dingemans K.P., van de Bergh Weerman M.A., Das P.K., Becker A.E. Specialized membrane contacts between immunocompetent cells in human atherosclerotic plaques. Cardiovasc Pathol. 3:1994;81-85.
7. Stemme S., Faber B., Holm J., Wiklund O., Witztum J.L., Hansson G.K. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA. 92:1995;3893-3897.
8. Rekhter M.D., Gordon D. Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. Am J Pathol. 147:1995;668-677.
9. Stemme S., Hansson G.K. Immune mechanisms in atherosclerosis. Coron Artery Dis. 5:1994;216-222.
10. Jenkins M.K., Taylor P.S., Norton S.D., Urdahl K.B. CD28 delivers a costimulatory signal involved in antigen specific IL-2 production by human T cells. J Immunol. 147:1991;2461-2466.
11. Harding F.A., McArthur J.G., Gross J.A., Raulet D.H., Allison J.P. CD28 mediated signaling costimulates murine T cells and prevent induction of anergy in T cell clones. Nature. 356:1992;455-459.
12. Mondino A., Jenkins M.K. Surface proteins involved in T cell costimulation. J Leukoc Biol. 55:1994;805-815.
13. Freedman A.S., Freeman G.J., Rhynart K., Nadler L.M. Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. Cell Immunol. 137:1991;429-437.
14. Vandenberghe P., Delabie J., de Boer M., De Wolf-Peeters C., Ceuppens J.L. In situ expression of B7/BB1 on antigen-presenting cells and activated B cells: an immunohistochemical study. Int Immunol. 5:1993;317-321.
15. Mitra R.S., Judge T.A., Nestle F.O., Turka L.A., Nickoloff B.J. Psoriatic skin-derived dendritic cell function is inhibited by exogeneous IL-10 differential modulation of B7-1 (CD80) and B7-2 (CD86) expression. J Immunol. 154:1995;2668-2677.
16. Shanafelt M.C., Soderberg C., Allsup A., Adelman D., Peltz G., Lahesmaa R. Costimulatory signals can selectively modulate cytokine production by subsets of CD4(+) T cells. J Immunol. 154:1995;1684-1690.
17. Armitage R.J. Tumor necrosis factor receptor superfamily members and their ligands. Curr Opin Immmunol. 6:1994;407-413.
18. Van Lier R.A., Borst J., Vroom T.M., Klein H., van Mourik H., Zeijlmaker W.P., Melief C.J.M. Tissue distrubution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J Immunol. 139:1987;1589-1596.
19. Hintzen R.Q., de Jong R., Lens S.M., van Lier R.A. CD27: marker and mediator of T-cell activation? Immunol Today. 15:1994;307-311.
20. Maurer D., Holter W., Majdic O., Fischer G.F., Knapp W. CD27 expression by a distinct subpopulation of human B lymphocytes. Eur J Immunol. 20:1990;2679-2684.
21. + CD4 T cell clones and involved in distinct immunoregulatory functions. J Immunol. 149:1992;3208-3216.
22. Agematsu K., Kobata T., Sugita K., Freeman G.J., Beckmann M.P., Schlossman S.F., Morimoto C. Role of CD27 in T cell immune response: analysis by recombinant soluble CD27. J Immunol. 153:1994;1421-1429.
23. Hintzen R.Q., Lens S.M., Koopman G., Pals S.T., Spits H., van Lier R.A. CD70 represents the human ligand for CD27. Int Immunol. 6:1994;477-480.
24. Hsu S.M., Raine L., Fanger H. Use of avidin biotin-peroxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 29:1981;577-580.
25. Van der Loos C.M., Das P.K., van den Oord J.J., Houthoff H.J. Multiple immunoenzyme staining techniques. Use of fluoresceinated, biotinylated and unlabeled staining techniques. J Immunol Methods. 117:1989;45-52.
26. Van der Loos C.M., van den Oord J.J., Das P.K., Houthoff H.J. Use of commercially available antibodies for immunoenzyme double staining. Histochem J. 20:1988;409-413.
27. Van der Wal A.C., Das P.K., Tigges A.J., Becker A.E. Macrophage differentiation in atherosclerosis. An in situ immunohistochemical analysis in humans. Am J Pathol. 141:1992;161-168.
28. Azuma M., Yssel H., Phillips J.H., Spits H., Lanier L.L. Functional expression of B7/BB1 on activated T lymphozytes. J Exp Med. 177:1993;845-850.
29. Ranheim E.A., Kipps T.J. Elevated expression of CD80 (B7/BB1) and other accessory molecules on synovial fluid mononuclear cell subsets in rheumatoid arthritis. Arthritis Rheum. 37:1994;1637-1646.
30. Verwilghen J., Lovis R., de Boer M., Linsley P.S., Haines G.K., Koch A.E., Pope R.M. Expression of functional B7 and CTLA4 on rheumatoid synovial T cells. J Immunol. 153:1994;1378-1385.
31. Nickoloff B.J., Nestle F.O., Zheng X.G., Turka L.A. T lymphocytes in skin lesions of psoriasis and mycosis fungoides express B7-1: a ligand for CD28. Blood. 83:1994;2580-2586.
32. Effros R.B., Boucher N., Porter V., Zhu X.M., Spaulding C., Walford R.L., Kronenberg M., Cohen D., Schachter F. Decline in CD28(+) T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp Gerontol. 29:1994;601-609.
33. Simon J.C., Dietrich A., Mielke V., Wuttig C., Vanscheidt W., Linsley P.S., Schöpf E., Sterry W. Expression of the B7/BB1 activation antigen and its ligand CD28 in T-cell-mediated skin diseases. J Invest Dermatol. 103:1994;539-543.
34. + T cell population: evidence that the CD4(+) CD45RA(-)CD27(-) T cell subset contains specialized primed T cells. J Immunol. 154:1995;17-25.
35. Lynch D.H., Ramsdell F., Alderson M.R. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today. 16:1995;569-574.